Suchergebnisse - "Naldi, Luigi"

PubPharm (438)

1

Ablative CO2-Assisted Laser for Topical Drug Delivery in Nail Psoriasis : A Systematic Review

enthalten in: Skin appendage disorders | 2024

von Tartaglia, J. | Piaserico, S. | Naldi, L. | +1

2

Actinic keratosis epidemiology : the good, the bad and the ugly

enthalten in: The British journal of dermatology | 2024

von Naldi, L. | Cassalia, F.

CommentOn: Br J Dermatol. 2024 Mar 15;190(4):465-476. - PMID 37890083

3

Comparison of Perceptions of Skin Condition, Product Use and Allergen Reactivity Between People with Psoriasis and Controls in the European Dermato-Epidemiology Network (EDEN) Fragrance Study

enthalten in: Acta dermato-venereologica | 2024

von Cassalia, F. | Cazzaniga, S. | Ofenloch, R. | +7

4

A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults

enthalten in: Expert review of clinical immunology | 2024

von Pezzolo, E. | Sechi, A. | Tartaglia, J. | +1

5

Melanoma detection : Evaluating the classification performance of a deep convolutional neural network and dermatologist assessment via a mobile app in an Italian real-world setting

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Cassalia, F. | Han, S. | Cazzaniga, S. | +1

6

Photoexposed Rash in an Older Adult

enthalten in: Cutis | 2024

von Mioso, G. | Naldi, L. | Sechi, A.

7

PRAME Updated : Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer

enthalten in: International journal of molecular sciences | 2024

von Cassalia, F. | Danese, A. | Tudurachi, I. | +7

8

Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis : An Italian Multicenter Analysis

enthalten in: Journal of clinical medicine | 2024

von Pezzolo, E. | Ortoncelli, M. | Ferrucci, S. | +18

9

Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms : A Delphi-Based International Consensus

enthalten in: JAMA dermatology | 2024

von Brüggen, M. | Walsh, S. | Ameri, M. | +60

10

Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults : A multicentre real-world study

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Pezzolo, E. | Schena, D. | Gambardella, A. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[44]